MAPT and Alzheimer disease: Assessment of the relationship of regional MTL tau burden extracted from tau PET and MTL subregional atrophy measures, similar to Das et al. (2018, 2019), Xie et al. (2018), but in the preclinical AD, should be done in the future work when sufficient tau PET data is available.